Beyond cardiac fibroblasts: research advances on understanding and targeting intercellular communication networks in cardiac fibrosis - Scorecard - MDSpire

Beyond cardiac fibroblasts: research advances on understanding and targeting intercellular communication networks in cardiac fibrosis

  • By

  • Xiduo Zhao

  • Lianyu Hua

  • Youjun Xiong

  • Fuyou Shi

  • Yilin Zhong

  • Shangwei Zhang

  • Chengnan Tian

  • July 1, 2026

  • 0 min

Share

Clinical Scorecard: Exploring Intercellular Communication Networks in Cardiac Fibrosis: Advances Beyond Cardiac Fibroblast Research

At a Glance

CategoryDetail
ConditionCardiac Fibrosis
Key MechanismsIntercellular communication networks involving cardiomyocytes, endothelial cells, and immune cells through paracrine signaling, direct cell-cell contact, and extracellular vesicle-mediated mechanisms.
Target PopulationPatients with cardiovascular diseases leading to heart failure.
Care SettingCardiology and cardiovascular research.

Key Highlights

  • Cardiac fibrosis is driven by a network of intercellular communication rather than solely by fibroblasts.
  • Signaling mediators from the pericardial space play a crucial role in fibrotic responses.
  • Immune cells, particularly macrophages, significantly contribute to the fibrotic signaling network.
  • Excessive ECM deposition leads to myocardial stiffness and impaired cardiac function.
  • Recent therapeutic strategies focus on multi-target interventions rather than single-target approaches.

Guideline-Based Recommendations

Diagnosis

  • Assess intercellular communication networks in cardiac fibrosis.

Management

  • Consider targeting specific cytokines and signaling pathways for therapy.

Monitoring & Follow-up

  • Evaluate changes in extracellular matrix composition and cardiac function.

Risks

  • Monitor for progressive myocardial hypertrophy and heart failure.

Patient & Prescribing Data

Patients with myocardial fibrosis due to various cardiovascular conditions.

Focus on multi-target combined strategies for effective anti-fibrotic therapy.

Clinical Best Practices

  • Utilize advanced technologies like single-cell sequencing to understand cardiac fibrosis.
  • Incorporate insights from immune cell interactions in treatment planning.
  • Evaluate the role of the extracellular matrix in regulating cellular communication.

Related Resources & Content

Original Source(s)

Related Content